Pricing Log in Create free account
Saturday 17 October 2026 Export BMY’s income statement to Excel — free account

Bristol Myers Squibb Company

BMY Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue grew 5.74%, EPS grew 153.1%, free cash flow fell 13.2% and total debt fell 12.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

59.71 0.86 −1.42%
Market cap
$123.7B
P/E
13.2×
Fwd P/E
11.2×
Dividend yield
4.22%
F-score
8/9
Altman Z
2.14
Beneish M
−2.69
Dividend safety
63/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bristol Myers Squibb Company (BMY) Gross margin

Alert me on Gross margin

Bristol Myers Squibb Company's gross margin over the twelve months to 30 June 2026 was 70.2%, down 0.9 percentage points from fiscal 2025 (71.1%). Over the past ten years it has ranged from 69.1% (fiscal 2019) to 78.6% (fiscal 2021); the current reading is higher than 36% of that period. That is in line with the Drug Manufacturers General industry median of 72.8% and above the Healthcare sector median of 53.5%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2025 71.1% 0.00
FY2024 71.1% (5.16)
FY2023 76.2% (1.80)
FY2022 78.0% (0.53)
FY2021 78.6% 6.26
FY2020 72.3% 3.21
FY2019 69.1% (2.24)
FY2018 71.3% 0.29
FY2017 71.1% (3.37)
FY2016 74.4% (1.97)

Quarterly newest first

Period Gross margin Change (points)
Jun 2026 71.3% 1.06
Mar 2026 70.2% 2.98
Dec 2025 67.2% (4.65)
Sep 2025 71.9% (0.63)
42 more quarters

Against its own ten years

Low 69.1% High 78.6%
Ten-year median 72.3%
Current reading's percentile 14

Gross margin against peers

Company Gross margin
AZN AstraZeneca PLC compare 81.9%
NVO Novo Nordisk A/S compare 80.7%
GILD Gilead Sciences, Inc. compare 79.6%
NVS Novartis AG compare 74.7%
PFE Pfizer Inc. compare 73.2%
SNY Sanofi compare 72.8%
GSK GSK PLC Sponsored ADR compare 72.8%
BMY Bristol Myers Squibb Company 70.2%
AMGN Amgen Inc. compare 69.5%
Drug Manufacturers General industry median 72.8%
Healthcare sector median 53.5%
Market median 46.2%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on BMY